Diaceutics PLC

Susanne Munksted, Chief Precision Medicine Officer at Diaceutics, will be speaking at the APM Annual Conference 2024 this weekend, November 1-2, in Philadelphia. Susanne's presentation, "How Can We Close the Clinical Practice Gaps in Precision Medicine?", builds on insights from Diaceutics’ globally recognized Practice Gaps paper, published in JCO in 2022. The paper revealed that 64% of aNSCLC patients were not receiving the most appropriate drug for their genetic profile. Susanne will discuss how these gaps have evolved, sharing new analysis and insights into the operational, economic, and policy challenges that continue to impact precision medicine. Susanne will also outline where the industry stands today and steps we can take to collaboratively close these gaps. If you’re attending, book a meeting with our team using the link below, and make sure to pick up your copy of the Recommendations paper! https://lnkd.in/e3SASEbz #PrecisionMedicine #PrecisionOncology #APM2024

New episode of the Better Testing, Better Treatment podcast coming soon! We’re happy to welcome guests Pr. Sophie Ferlicot, Anatomopathologist and Dr. Mario Terlizzi, Radiation Oncologist, as they explore the ever-evolving role of artificial intelligence in one of the most prevalent cancers. The Better Testing, Better Treatment podcast explores the opinions of both a clinician and a pathologist on new and upcoming lab-based topics and you can catch up on all previous episodes now: https://lnkd.in/e-E_GUCu

Are you facing challenges identifying and engaging physicians for your precision medicine therapy? Don't miss our next webinar in the Precision Medicine Series! Gosia Leitch, VP of Engagement Solutions at Diaceutics, will share how data-driven, omnichannel strategies can enhance physician engagement by precisely targeting physicians treating patients with relevant biomarkers. Discover how to leverage prospective diagnostics data to reach physicians at the right time within the treatment decision window, and learn how to design effective omnichannel education to drive adoption of novel biomarkers and treatments. Gosia will also share examples of successful educational campaigns and metrics for tracking ROI. Join us for this webinar on November 13th from 1-2 pm EST. Register here: https://lnkd.in/ep--Jn6f #PrecisionMedicine #HealthcareInnovation #Webinar

Last chance to register! Join us today at 2.30pm, CET. Prof Pruneri Giancarlo joins us to share expert insights on biomarker testing for ADC in cancer patients, sharing considerations from a pathologist point of view in terms of the importance of biomarker selection and on-target, off-tumor toxicity (OTOT). https://lnkd.in/eYhGMTWR  

There's still time to register for our next LabTalk! Join us tomorrow by registering now: https://lnkd.in/e_hcJAQF We will be joined by Prof Pruneri Giancarlo as he discusses the status of ADC use in cancer treatment, sharing considerations from a pathologist point of view in terms of the importance of biomarker selection and on-target, off-tumor toxicity (OTOT).

Miss the live session? Catch-up on the recording of our latest Lab Talk with Dr. Kurt Schalper as he discusses pathogenic gene fusions as oncogenic drivers and actionable biomarkers in precision oncology, focusing on NRG1 fusions.  https://lnkd.in/e5599VVy  

50% of patients are not receiving appropriate testing for biomarker-guided treatment due to inefficiencies stemming from inadequate market development planning for companion diagnostic (CDx) tests (Pharma Precision Medicine Readiness Report, 2019). Awareness among physicians regarding biomarker tests is crucial, as a lack of understanding around new biomarkers and their associated therapies leads to slow clinical uptake. Read more in our blog below: https://lnkd.in/e3JPvydT Join Gosia Leitch, VP of Engagement Solutions at Diaceutics to explore how data driven omnichannel strategies can enhance physician engagement by precisely targeting physicians treating patients with relevant biomarkers. Discover how leveraging lab data can accelerate the adoption of novel treatments, enabling rapid engagement with physicians within 24 hours after a patient tests positive for a relevant biomarker. Register here: https://lnkd.in/ep--Jn6f #PrecisionMedicine #HealthcareInnovation #Webinar

Join Gosia Leitch, VP of Engagement Solutions on November 13th, 1-2PM EST, for our next webinar in the Precision Medicine Webinar Series: - Understand why precision medicine commercial success requires a different approach to clinical education. - Discover how data driven omnichannel marketing allows precise targeting and timing of engagement. - Learn how you can utilize prospective diagnostics data to reach physicians at the right time when they make treatment recommendations. - Discover how to design your omnichannel education to accelerate novel biomarker and treatment adoption. - Discuss examples of educational campaigns and metrics that have been used to track ROI. Register for webinar here: https://lnkd.in/ep--Jn6f #PrecisionMedicine #HealthcareInnovation #Webinar 

Mark your calendars for our latest episode release!   Artificial Intelligence in Prostate Cancer: from clinic to lab  - coming 13th November The Better Testing, Better Treatment podcast is thrilled to welcome guests Pr. Sophie Ferlicot, Anatomopathologist and Dr. Mario Terlizzi, Radiation Oncologist, for an informative episode with industry experts! Pr. Sophie Ferlicot and Dr. Mario Terlizzi will draw you into a compelling discussion about AI's applications in prostate cancer care, including diagnostics (imaging and histological assessment), and therapeutics.     With the flourishing landscape of clinical research and numerous advancements improving prognosis in recent years for prostate cancer, this isn’t an episode to miss! As we wait for the next release, why not catch up on previous episodes in the series? https://lnkd.in/eVTamKGV

We are thrilled to announce that we have won the Innovation of the Year award for DXRX Signal at the prestigious Pharma Industry Awards 2024! This recognition is a testament to our team’s hard work, dedication, and relentless pursuit of excellence. Our award-winning product, DXRX Signal, allows our pharma partners to identify brand-eligible patients in real-time by delivering an actionable alert within 24 hours of a specified testing event, allowing timely engagement of HCPs during the critical treatment decision timeframe to maximize the effectiveness of a brand’s sales and marketing activities. The Pharma Industry Awards, held on September 18th at the ICC in Birmingham, celebrate the most innovative and outstanding achievements in the UK’s pharmaceutical sector. It was an honor to be among such esteemed companies and individuals who are driving excellence and making significant contributions to the industry. Jordan Clark, Chief Data Officer at Diaceutics, commented, “This recognition from Pharma Industry Awards 2024 is a testament to the dedication and hard work of multiple teams at Diaceutics. Through the development and deployment of DXRX Signal, we are able to fulfil our mission: Every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcomes.” A huge thank you to our incredible team, partners, and supporters who made this achievement possible. We are excited to continue pushing the boundaries of innovation and making a positive impact on healthcare worldwide. #PharmaIndustryAwards #InnovationOfTheYear #DXRXSignal #PharmaExcellence #TeamSuccess